- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tislelizumab (BGB-A317)
Total 1614 results
-
BeiGeneCompletedLocally Advanced or Metastatic Urothelial Bladder CancerKorea, Republic of, China
-
BeiGeneCompletedCutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditionsChina, Taiwan, Germany, France, Canada, Italy
-
BeiGeneCompletedClassical Hodgkin LymphomaChina
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
West China HospitalRecruiting
-
BeiGeneTerminatedAdvanced Solid TumorsAustralia, Spain, New Zealand
-
BeiGeneRecruitingNon-small Cell Lung CancerChina, Georgia, Moldova, Republic of
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletedSolid TumorsUnited States, Spain, United Kingdom, France, Australia, New Zealand
-
BeiGeneCompletedAdvanced Solid TumorsChina, Australia
-
BeiGeneRecruitingMSI-H/dMMR Solid TumorsChina
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
BeiGeneActive, not recruiting
-
BeiGeneRecruitingSolid Tumor | Advanced Solid Tumor | Metastatic Solid TumorUnited States, France, Australia
-
Qilu Hospital of Shandong UniversityNot yet recruitingHER2-positive Gastric CancerChina
-
BeiGeneRecruitingAdvanced Solid TumorsUnited States, Australia, Spain
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
BeiGeneRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaChina, Italy, Taiwan, Australia, Spain, Korea, Republic of, France, Thailand, United States, Georgia, Singapore, Canada
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
BeiGeneLymphoma Study AssociationActive, not recruitingClassical Hodgkin LymphomaUnited States, Australia, France, Belgium, Puerto Rico
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingChemotherapy | Gastric Cancer Stage IV | Tislelizumab | First-lineChina
-
BeiGeneActive, not recruitingResectable Esophageal Squamous Cell CarcinomaChina
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
BeiGeneActive, not recruiting
-
BeiGeneCompleted
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
UNICANCERRecruitingTesting Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions (HESTIA)Hepatocellular Carcinoma by BCLC StageFrance
-
BeiGeneCompletedLimited Stage Small Cell Lung CancerChina, Korea, Republic of, United States
-
BeiGeneCompletedAdvanced Hepatocellular CarcinomaChina, Taiwan
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Hunan Cancer Hospital; Cancer Hospital of Guizhou... and other collaboratorsActive, not recruiting
-
BeiGeneCompletedHepatocellular Carcinoma (HCC)Spain, China, Taiwan, Germany, Italy, United Kingdom, France, Poland
-
BeiGeneActive, not recruitingNonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)United States, China, Korea, Republic of, France, Spain, Australia, Austria
-
HiFiBiO TherapeuticsRecruitingMelanoma | Sarcoma | Renal Cell Carcinoma | Cervical Cancer | Testicular Germ Cell Tumor | Gastric Cancer | Non Small Cell Lung Cancer | Mesothelioma | Head and Neck Squamous Cell CarcinomaUnited States, Spain
-
Seoul National University HospitalBeiGeneActive, not recruitingAdvanced Biliary Tract CancerKorea, Republic of
-
HiFiBiO TherapeuticsRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Non Small Cell Lung CancerSpain, United States, Italy
-
Sidney Kimmel Comprehensive Cancer Center at Johns...BeiGene; Syntrix Biosystems, Inc.RecruitingPancreatic CancerUnited States
-
BeiGeneCompletedEsophageal Squamous Cell CarcinomaKorea, Republic of, Spain, China, Thailand, Taiwan, France
-
BeiGeneRecruitingEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma by AJCC V8 StageChina, Taiwan, Korea, Republic of, Thailand
-
HutchmedBeiGeneActive, not recruitingSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Neuroendocrine Tumors | Metastatic Solid Tumor | Anaplastic Thyroid CancerUnited States
-
Zhejiang UniversityShandong Cancer Hospital and Institute; First Hospital of China Medical University and other collaboratorsRecruitingHepatocellular Carcinoma | Adjuvant TherapyChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityBeiGeneNot yet recruitingUrinary Bladder NeoplasmsChina
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
Peking University Cancer Hospital & InstituteRecruitingColorectal Liver MetastasesChina
-
BeiGeneHutchison Medipharma LimitedCompletedAdvanced Solid TumorsKorea, Republic of, China
-
Hutchison Medipharma LimitedBeiGeneActive, not recruitingColorectal Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Solid Tumor, Unspecified, AdultUnited States
-
BeiGeneCompletedLymphoma | LeukemiaChina, Australia
-
BeiGeneRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingAdvanced Hepatocellular CarcinomaTaiwan